
A single subcutaneous dose led to a 4-point or greater itch reduction in 82% of patients with chronic pruritus at week 12 vs 22% with placebo, Attovia reported.
Many dermatologists agree that it's wonderful to have so many tools, but each one serves a purpose for enhancing different features and areas of the face.
At the 2013 Vegas Cosmetic Surgery and Aesthetic Dermatology meeting, a group of panelists discussed their preferred injectable products, how they use them and why they choose them. Many agree that it's wonderful to have so many tools and that each one serves a purpose for enhancing different features and areas of the face.
Video credit: xMedica






